Global Technologies Ltd. (GTLL)
OTC PINK OTC PINK Primary 
Enad Global 7 AB (publ) (ENADF) Q4 2025 Earnings Call Transcript
Enad Global 7 AB (publ) (ENADF) Q4 2025 Earnings Call Transcript
ReNew Energy Global: Volatile, Leveraged, And Worth The Risk
ReNew Energy Global remains a Buy, driven by robust revenue growth, manufacturing momentum, and supportive regulatory tailwinds despite elevated debt and execution risks. RNW's Q3 revenue surged 48% YoY, with manufacturing EBITDA up sharply; asset recycling and domestic content rules enhance revenue visibility and competitive positioning. Valuation appears attractive: RNW trades at a 22% EV/EBITDA discount to sector peers and a price-to-cash-flow ratio 76% below the sector average.
Coinbase Global Posts a Soft Q4 Earnings: Here's How to Play the Stock
Coinbase Global posts a soft Q4 with revenue and EPS misses, as transaction fees fall but subscription growth and 2026 plans keep focus on rebound.
Subscription Model & Acquisitions Aid S&P Global Amid Low Liquidity
SPGI's subscription revenues and acquisitions fuel growth, but rising costs, liquidity strain and fierce competition cloud its outlook.
Healthy Global Loan Issuance Volumes to Drive Moody's Q4 Earnings
MCO heads into Feb. 18 earnings with healthy Q4 loan and bond issuance driving MIS growth, while Analytics demand and rising acquisition costs shape results.
The SaaS-pocalypse Crushes S&P Global — Is the Data Giant a Screaming Buy?
S&P Global ( NYSE:SPGI ) shares have plunged due to the so-called “SaaS-pocalypse” sell-off that hit software-as-a-service stocks hard.
ARS Pharmaceuticals: Climbing Neffy Sales And Global Expansion Could Re-Rate The Stock
SPRY's main product is Neffy, which is a needle-free epinephrine spray. Its sales are ramping quickly, and Q3 2025 sales hit $31.3 million. My core thesis is that Neffy's more convenient delivery mechanism will resonate with patients far better than injections. Also, a convenient nasal spray is a much simpler administration method that should reduce user error and unlock diagnosed-but-untreated anaphylaxis demographics.
Apollo Global: Overdone Credit Fears Create A Buying Opportunity (Upgrade)
Apollo Global Management is upgraded to "Buy" after a 20% share price decline, despite robust recurring revenue and strong fundraising. APO's Q4 saw record fee-related earnings, 25% AUM growth to $938 billion, and $42 billion in quarterly inflows, supporting double-digit growth visibility. Credit risk concerns, especially in software and private credit, appear overdone given APO's low sector exposure and predominantly investment-grade portfolio.
Grupo Cibest: A Good Diversification Play In The Global Banking Sector
Grupo Cibest S.A. stands out as a leading Colombian banking group, combining strong growth prospects, high profitability, and attractive valuation versus Latam peers. CIB benefits from a flexible holding structure, robust digital platforms like Nequi, and a strategic focus on core markets and digital expansion. Recent and expected interest rate hikes in Colombia are poised to boost CIB's net interest income and profitability, with ROE likely exceeding previous guidance.
Carrier Global's Quiet Dividend Strategy Deserves Attention
Mastercard just distributed $0.87 per share to shareholders on February 9, 2026, marking the payment network's latest quarterly dividend.
BASF Strengthens Business Services Through Global Hub Setup
BASF advances its Global Business Services overhaul with a new India hub to boost efficiency, resilience and scalable support worldwide.
S&P Global Stock Now 32% Cheaper: Is It Time To Buy?
S&P Global (SPGI) stock could be a promising purchase at this moment. Why is that?
